financetom
Business
financetom
/
Business
/
Masco's Q2 Adjusted Net Income Rises, Sales Fall; 2024 Adjusted EPS Outlook Revised
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Masco's Q2 Adjusted Net Income Rises, Sales Fall; 2024 Adjusted EPS Outlook Revised
Jul 25, 2024 5:06 AM

07:38 AM EDT, 07/25/2024 (MT Newswires) -- Masco ( MAS ) reported Q2 adjusted net income Thursday of $1.20 per share, up from $1.19 a year earlier.

Analysts polled by Capital IQ expected $1.18.

Net sales for the quarter ended June 30 were $2.09 billion, down from $2.13 billion a year earlier.

Analysts surveyed by Capital IQ expected $2.10 billion.

For 2024, the company said it now expects adjusted EPS in the range of $4.05 to $4.20, compared with its prior outlook of $4.00 to $4.25. Analysts polled by Capital IQ expect $4.09.

Additionally, Masco's ( MAS ) board maintained its quarterly dividend at $0.29 per share, payable Aug. 19 to shareholders of record as of Aug. 2.

Masco's ( MAS ) stock was nearly 5% higher in recent Thursday premarket activity.

Price: 74.00, Change: +3.42, Percent Change: +4.85

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Kane Biotech Extends Exclusivity Period on its Offer for its Interest in STEM Animal Health
Kane Biotech Extends Exclusivity Period on its Offer for its Interest in STEM Animal Health
Mar 20, 2024
01:17 PM EDT, 03/20/2024 (MT Newswires) -- Kane Biotech Inc. ( KNBIF ) announces that it has extended the exclusivity period on the offer for its interest in STEM Animal Health that it announced on December 20, 2023, from March 19, 2024 until March 31, 2024. Kane also reports that, subsequent to the US$625,000 deposit that it received at the...
CERAWEEK-Vale expects nickel market deficit by 2028, executive says
CERAWEEK-Vale expects nickel market deficit by 2028, executive says
Mar 20, 2024
(Corrects headline to show expectation for deficit, not surplus) HOUSTON, March 19 (Reuters) - Brazilian miner Vale expects nickel markets to swing to a global deficit by 2028 from their current oversupply, an executive said on Tuesday. We are very strong on nickel fundamentals, Vale Chief Sustainability and Corporate Affairs Officer Emily Olson told the CERAWeek energy conference in Houston....
Alzheimer's-Focused Small Cap Firm IGC Pharma Releases Data,  Candidate Reduces Agitation Compared To Placebo
Alzheimer's-Focused Small Cap Firm IGC Pharma Releases Data, Candidate Reduces Agitation Compared To Placebo
Mar 20, 2024
Wednesday, IGC Pharma Inc ( IGC ) announced the results of an interim analysis of its ongoing Phase 2 trial of IGC-AD1 for Agitation in Dementia from Alzheimer’s Disease (AAD). The interim data demonstrates a clinical and statistically significant reduction in agitation compared to placebo in patients with Alzheimer’s disease. The study’s primary goal is to assess the change in AAD after six...
Hilton Worldwide to Remain Resilient in a Recession, Macquarie Says
Hilton Worldwide to Remain Resilient in a Recession, Macquarie Says
Mar 20, 2024
01:20 PM EDT, 03/20/2024 (MT Newswires) -- Hilton Worldwide Holdings ( HLT ) will remain resilient in a recession as franchised hotels drive 80% of fees, Macquarie Equity Research said in a note. We believe investors will continue to view positively the consistent fee growth, [6% to 7% net unit growth] outlook and capital returns story, Macquarie said. The firm...
Copyright 2023-2026 - www.financetom.com All Rights Reserved